HRI Pfeiffer Treatment Center Joins Facebook Ranks

* Reuters is not responsible for the content in this press release.

Thu May 21, 2009 10:00am EDT

Launches campaign to increase patient awareness
WARRENVILLE, Ill.--(Business Wire)--
HRI Pfeiffer Treatment Center announces the launch of its social networking page
on "Facebook" for the local Autism and attention deficit disorder community. 

The goal of this launch is to increase awareness of Pfeiffer`s cutting edge
research and available treatment options. 

"We are excited to offer a novel way to engage the Autism community other than
our website to keep our existing and potential patients informed of our
developments, as well as new therapies" says Scott Filer, Executive Director of
HRI Pfeiffer Treatment Center. 

The treatment center`s Facebook presence will also promote awareness in a number
of ways, including various email notices of informational seminars, conferences,
published research articles and fundraising events promoting autism, ADD/ADHD
and other disorders that the center treats. 

Individuals can follow HRI Pfeiffer Treatment Center on Facebook at
http://www.facebook.com/pages/Pfeiffer-Treatment-Center/91782287649

For more information, please contact Mark LaShure at Pfeiffer Treatment Center
at 630 505-0300 x279. 

ABOUT HRI PFEIFFER TREATMENT CENTER 

The HRI Pfeiffer Treatment Center is a not-for-profit medical research and
treatment facility in Warrenville, Illinois specializing in research and
treatment of biochemical imbalances through non-drug therapies. Since the center
opened in 1989, it has treated over 20,000 patients who suffer from behavior
dysfunctions, depression, schizophrenia, bipolar disorder, autism, learning
disorders, or anxiety by balancing body and brain chemistry. For more
information about HRI Pfeiffer Treatment Center, visit www.hriptc.orgor call
630-505-0300. 





HRI Pfeiffer Treatment Center
Mark LaShure, 630 505-0300 x279 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.